• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci USA. Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection

Giuseppe

Emeritus
Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection (PNAS, abstract, edited)


[Source: Proc Natl Acad Sci USA, full text: <cite cite="http://www.pnas.org/content/108/14/5661.short?rss=1">Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection</cite>. Abstract, edited.]

Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection

1. Rebecca Batorsky a, 2. Mary F. Kearney b, 3. Sarah E. Palmer b, 4. Frank Maldarelli b, 5. Igor M. Rouzine c,1, and 6. John M. Coffin c,1

Author Affiliations
1. a Department of Physics and Astronomy, Tufts University, Medford, MA 02155;
2. b HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702; and
3. c Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111

1. Contributed by John M. Coffin, February 7, 2011 (sent for review December 18, 2010)


Abstract

HIV adaptation to a host in chronic infection is simulated by means of a Monte-Carlo algorithm that includes the evolutionary factors of mutation, positive selection with varying strength among sites, random genetic drift, linkage, and recombination. By comparing two sensitive measures of linkage disequilibrium (LD) and the number of diverse sites measured in simulation to patient data from one-time samples of pol gene obtained by single-genome sequencing from representative untreated patients, we estimate the effective recombination rate and the average selection coefficient to be on the order of 1% per genome per generation (10−5 per base per generation) and 0.5%, respectively. The adaptation rate is twofold higher and fourfold lower than predicted in the absence of recombination and in the limit of very frequent recombination, respectively. The level of LD and the number of diverse sites observed in data also range between the values predicted in simulation for these two limiting cases. These results demonstrate the critical importance of finite population size, linkage, and recombination in HIV evolution.

* modeling
* clonal interference
* background selection
* hitchhiking
* haplotype

Footnotes

* ↵1To whom correspondence may be addressed. E-mail: irouzine@tufts.edu or john.coffin@tufts.edu.
* Author contributions: R.B., I.M.R., and J.M.C. designed research; R.B., M.F.K., S.E.P., F.M., and I.M.R. performed research; M.F.K., S.E.P., F.M., and J.M.C. contributed new reagents/analytic tools; R.B. and I.M.R. analyzed data; and R.B., I.M.R., and J.M.C. wrote the paper.
* The authors declare no conflict of interest.

-
------
 
Back
Top Bottom